NT 10-Q ·Filed Nov 16, 2026
Late quarterly filing (signals accounting problems)
BIXT drugs
BIXT drug pipeline →Price Chart
Loading chart...
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| NT 10-Q Filing (Primary) | 0001493152-26-052609 |
| Document: 0001493152-26-052609-index-headers.html | 0001493152-26-052609 |
| Document: 0001493152-26-052609-index.html | 0001493152-26-052609 |
| Document: 0001493152-26-052609.txt | 0001493152-26-052609 |
Track record
4 reports on BIXT
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today NT 10-Q Bearish 6/10 Viewing Entry $0.0220 Now $0.0222 −0.91% settles Feb 16
- Nov 16, 2026today 8-K Neutral 3/10 Entry $0.0220 Now $0.0222 +0.91% settles Feb 12
- Nov 4, 202612d ago 8-K Neutral 3/10 Entry $0.0230 Now $0.0222 −3.48% settles Feb 3
- Aug 11, 202613w ago 8-K Bullish 5/10 Entry $0.0248 to $0.0205 Now $0.0222 −10.48% ▼ −17.34% −17.20% vs SPY
Showing 4 of 4
US Market Status
Market Closed · Opens in 5h 27m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers